whatpeptidestostack
← Compound library
PT-141 and Tirzepatide
Co-administeredA registered trial has begun giving both compounds to the same subjects. No result has been reported, so the pairing is a registration, not a finding.
How the two mechanisms relate
Synergy. PT-141 is a melanocortin-receptor agonist and Tirzepatide a dual-incretin agonist, two distinct receptor pathways, and the two were co-administered in a registered study.
This part is our reading of the mechanism. The grade above is what the published record shows.
The compounds
PT-141
A melanocortin receptor agonist with one approved use and a disputed effect size. It has one pairing in this atlas from a study that gave two compounds to the same subjects.
Full profile, dosing and safety →Tirzepatide
Tirzepatide is covered here for research context only. Research orders for it go to Peptara Labs by WhatsApp message.
Full profile, dosing and safety →